NAYA Biosciences And ONK Therapeutics Announce Research Partnership To Advance Combination Therapy Of FLEX-NK Bispecific Antibodies And Optimally Engineered Off-The-Shelf Natural Killer Cell Therapies
NAYA Biosciences and ONK Therapeutics to assess proof-of-concept and establish activity and feasibility of the combination of NAYA's FLEX-NK™ bispecific antibodies and ONK's optimally engineered natural killer